CVS suspends sales of Zantac due to possible link to cancer
WOONSOCKET, RI - CVS customers will no longer find Zantac on store shelves, at least for the time being.
CVS has announced their decision to suspend the selling of the popular heartburn medication while it's being investigated for a possible link to cancer.
On September 13, the US Food and Drug Administration (FDA) informed the public of their decision to review the presence of N-nitrosodimethylamine (NDMA) in medicines containing the drug ranitidine.
Ranitidine products, such as Zantac, are used to reduce the production of stomach acid in patients with conditions like heartburn and stomach ulcers.
Health authorities say there is no immediate risk, but advise patients to consult a doctor who can prescribe alternatives to ranitidine.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Restaurants facing broken food supply chains due pandemic
Driver shot during Iberville police chase was fleeing law enforcement with his...
Turnout remains low at federally-backed mass vaccination sites
Cryptocurrency making a wave in Baton Rouge, lawmakers hope to create rules...
Louisiana governor urges feds to resume offshore leases in months
LSU pitcher Matt Beck gets his moment at the plate
Brusly baseball needs extra innings to win regional series with Jennings.
Southern Athletic Director Roman Banks talks about coaching search
Drew Brees and Sean Payton enjoy the Zurich Classic
Legendary Parkview coach Kenny Guillot passes away at 76